Author: claimsbot

1. A method for management of data transmission in a geographical information system in which a spatial environment is represented according to representation data with reference to geographical areas; said geographical information system comprising a server and a terminal connected via a communication network; the server storing the representation data according to the geographical areas; said method comprising the following, carried out at the level of the terminal:
selecting a plurality of geographical areas as a function of a criterion relating to a current load level of the terminal;
sending a request to the server indicating said plurality of geographical areas selected; and
receiving representation data according to a continuous transmission protocol.
2. The management method according to claim 1:
wherein the representation data are of different types; and
wherein at least one data type is chosen per geographical area selected from the plurality of geographical areas.
3. The management method according to claim 1, wherein selecting the plurality of geographical areas is also a function of a current load level of the communication network.
4. The management method according to claim 1:
wherein the request from the terminal to the server indicates a current location and an orientation in the spatial environment; and
wherein the representation data received correspond to the representation data adapted to the current location and to the orientation in the spatial environment.
5. A method for the management of data transmission in a geographical information system in which a spatial environment is represented according to representation data with reference to geographical areas; said geographical information system comprising a server and a terminal connected via a communication network; the server storing the representation data according to the geographical areas; said method comprising the following, carried out at the level of the server:
receiving, at the server, a request indicating a plurality of geographical areas;
determining representation data according to said plurality of geographical areas; and
transmitting said representation data to the terminal according to a continuous transmission protocol.
6. The data management method according to claim 5:
wherein the request from the terminal to the server indicates a current location and an orientation in the spatial environment; and
wherein the transmitted representation data are selected according to the current location and orientation in the spatial environment.
7. A terminal in a geographical information system in which a spatial environment is represented according to representation data with reference to geographical areas; said geographical information system comprising a server connected to the terminal via a communication network; the server storing the representation data according to the geographical areas; said terminal comprising:
a selection unit capable of selecting a plurality of geographical areas as a function of a criterion relating to a current load level of the terminal;
a transmission unit capable of sending a request to the server indicating said plurality of geographical areas selected; and
a receiving unit capable of receiving representation data according to a continuous transmission protocol.
8. A server in a geographical information system in which a spatial environment is represented according to representation data with reference to geographical areas; said geographical information system comprising a terminal connected to the server via a communication network; the server comprising:
a database adapted to store the representation data according to the geographical areas;
a receiving unit adapted to receive a request indicating a plurality of geographical areas;
a determination unit adapted to determine representation data according to said plurality of geographical areas; and
a transmission unit adapted to transmit said representation data to the terminal according to a continuous transmission protocol.
9. A geographical information system in which a spatial environment is represented according to representation data with reference to geographical areas; said system comprising a terminal according to claim 7 and a server according to claim 8.
10. A computer program comprising instructions for implementing a method for the management of the reception of data according to claim 1 when this program is executed by a processor.
11. A computer program comprising instructions for implementing a method for the management of data transmission according to claim 5 when this program is executed by a processor.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method for inducing stasis in in vivo biological matter comprising:
a) identifying an organism in which stasis is desired; and,
b) exposing the organism to an effective amount of a oxygen antagonist to induce stasis of the in vivo biological matter.
2. The method of claim 1, wherein the effective amount is a sublethal dose of the oxygen antagonist.
3. The method of claim 1, wherein the effective amount is a near-lethal dose of the oxygen antagonist.
4. The method of claim 1, wherein the oxygen antagonist is a reducing agent.
5. The method of claim 1, wherein the oxygen antagonist is a chalcogenide compound.
6. The method of claim 5, wherein the chalcogenide compound comprises sulfur.
7. (canceled)
8. (canceled)
9. (canceled)
10. The method of claim 11, wherein the reducing agent is a chalcogenide compound.
11. The method of claim 4, wherein the reducing agent has a chemical structure of
wherein X is N, O, Po, S, Se, or Te;
wherein Y is N or O;
wherein R1 is H, C, lower alkyl, a lower alcohol, or CN;
wherein R2 is H, C, lower alkyl, or a lower alcohol, or CN;
wherein n is 0 or 1;
wherein m is 0 or 1;
wherein p is 1 or 2 and,
wherein k is 0, 1, 2, 3, or 4.
12. The method of claim 11, wherein the reducing agent is selected from the group consisting of H2S, H2Se, H2Te, and H2Po.
13. The method of claim 11, wherein X is S.
14. (canceled)
15. (canceled)
16. (canceled)
17. The method of claim 11, wherein X is O.
18. The method of claim 13, wherein k is 0 or 1.
19. The method of claim 18, wherein k is 0.
20. The method of claim 11, wherein the reducing agent is DMSO, DMS, carbon monoxide, methylmercaptan (CH3SH), mercaptoethanol, thiocyanate, hydrogen cyanide, MeSH, or CS2.
21. The method of claim 1, wherein the oxygen antagonist is a gas, semi-solid liquid, or liquid.
22. The method of claim 21, wherein the oxygen antagonist is a gas.
23. (canceled)
24. The method of claim 22, wherein the gas comprises carbon monoxide, sulfur, selenium, tellurium, or polonium, or a mixture thereof.
25. (canceled)
26. (canceled)
27. (canceled)
28. The method of claim 24, wherein the biological matter is exposed to an amount of the oxygen antagonist that reduces the rate or amount of carbon dioxide production by biological matter or organism at least about two-fold.
29. The method of claim 24, wherein the biological matter is exposed to an amount of the oxygen antagonist that reduces the rate or amount of oxygen consumption by at least about two-fold.
30. The method of claim 24, wherein the biological matter is an organism, and the organism is exposed to an amount of the oxygen antagonist that decreases movement or motility by at least about 10%.
31. The method of claim 1, further comprising subjecting the biological matter andor organism to a controlled temperature environment.
32. The method of claim 31, wherein the controlled temperature environment is at a non-physiological temperature for the tissue.
33. The method of claim 31, wherein the controlled temperature environment is between about \u2212210\xb0 C. and about 50\xb0 C.
34. (canceled)
35. The method of claim 33, wherein the controlled temperature environment is between about \u221220\xb0 C. and about 4\xb0 C.
36. The method of claim 33 wherein the controlled temperature environment is between about 0\xb0 C. and about 50\xb0 C.
37. The method of claim 36, wherein the tissue achieves a core temperature of between 4\xb0 C. and about 28\xb0 C.
38. (canceled)
39. (canceled)
40. (canceled)
41. (canceled)
42. The method of claim 31, wherein the tissue is subjected to a controlled temperature environment before, during or after exposure to the oxygen antagonist.
43. The method of claim 31, wherein the biological matter is subjected to a controlled temperature environment for a period of time between about one minute and about one year.
44. The method of claim 31, further comprising modulating environmental oxygen levels or removing the biological material or organism from an environment having oxygen.
45. The method of claim 1, further comprising assessing the level of the oxygen antagonist andor oxidative phosphorylation in the biological matter or organism.
46. The method of claim 1, further comprising removing the oxygen antagonist.
47. (canceled)
48. The method of claim 31, wherein the oxygen antagonist is a chalcogenide compound.
49. The method of claim 24, wherein the gas is a gas mixture comprising more than one gas.
50. (canceled)
51. (canceled)
52. (canceled)
53. The method of claim 52, wherein the gas misture comprises hydrogen, helium, nitrogen, neon, argon, xenon, krypton, or ununoctium.
54. The method of claim 24, wherein the gas is mixed with oxygen to form an oxygen gas mixture.
55. The method of claim 54, wherein the amount of oxygen in the oxygen gas mixture is less than the total amount of all other gas or gases in the mixture.
56. The method of claim 54, wherein the gas is carbon monoxide and the amount of carbon monoxide is about the same or exceeds any amount of oxygen in the oxygen gas mixture.
57. The method of claim 21, wherein the biological matter or organism is exposed to the oxygen antagonist in a closed environment.
58. (canceled)
59. (canceled)
60. The method of claim 57, wherein exposing the biological matter to the oxygen antagonist comprises covering or enclosing the biological matter or organism with or within a container that maintains the environment.
61. The method of claim 57, further comprising placing the biological matter or organism under a vacuum.
62. (canceled)
63. The method of claim 1, wherein the biological matter is exposed to the oxygen antagonist in an environment that is at room temperature.
64. The method of claim 56, wherein the ratio of carbon monoxide to oxygen is at least about 199:1.
65. The method of claim 64, wherein the wherein the ratio of carbon monoxide to oxygen is at least about 399:1.
66. (canceled)
67. The method of claim 1, wherein the biological matter is exposed to the oxygen antagonist by perfusion with incubation with, in section, ingestion of, or administering the oxygen antagonist.
68. (canceled)
69. (canceled)
70. The method of claim 67, wherein the biological matter or organism is perfused or incubated with the oxygen antagonist for a period of about one minute to about one week.
71. The method of claim 70, wherein the biological matter or organism is perfused or incubated with the oxygen antagonist for a period of about 5 minutes to about 24 hours.
72. (canceled)
73. (canceled)
74. The method of claim 70, wherein the biological matter is perfused or incubated with the oxygen antagonist for at least 2 hours.
75. (canceled)
76. (canceled)
77. The method of claim 67, wherein the oxygen antagonist is administered to the biological matter or organism intravenously, intradermally, intraarterially, intraperitoneally, intralesionally, intracranially, intraarticularly, intraprostaticaly, intrapleurally, intratracheally, intranasally, intravitreally, intravaginally, intrarectally, topically, intratumorally, intramuscularly, intraperitoneally, intraocularly, subcutaneously, subconjunctival, intravesicularlly, mucosally, intrapericardially, intraumbilically, intraocularally, orally, topically, locally, by inhalation, by injection, by infusion, by continuous infusion, by localized perfusion, via a catheter, or via a lavage.
78. The method of claim 1, wherein the organism is a mammal.
79. The method of claim 78, wherein the mammal is human.
80. The method of claim 78, wherein the mammal is a dog, a cat, a monkey, a pig, a cow, a horse, a rabbit, a rat, a mouse, a baboon, or a sheep.
81. The method of claim 78, wherein the mammal has been subjected to a physical trauma.
82. The method of claim 1, wherein the trauma is surgery, stroke, heart attack, bone fracture, soft tissue damage, internal bleeding, organ damage, amputation, concussion, andor burns.
83. The method of claim 1, wherein the mammal is at risk for or is in hemorrhagic shock.
84. The method of claim 81, wherein the trauma is caused by a gunshot, a shrapnel wound, or a knife wound.
85. The method of claim 1, wherein the biological material or organism is diseased or has a disease.
86. The method of claim 85, wherein the disease is an infectious disease.
87. The method of claim 85, wherein the disease is a hyperproliferative disease.
88. The method of claim 87, wherein the disease is cancer.
89. The method of claim 85, wherein the disease is a neurodegenerative disease.
90. The method of claim 89, wherein the neurodegenerative disease is selected from the group consisting of Alzheimer’s disease and Parkinson’s disease.
91. The method of claim 85, wherein the disease is an inflammatory disease.
92. The method of claim 91, wherein the inflammatory disease is ulcerative colitis.
93. The method of claim 91, wherein the inflammatory disease is transplant rejection or an autoimmune disease.
94. The method of claim 78, wherein the mammal will undergo surgery.
95. The method of claim 1, wherein the biological matter is an organ, tissue, or cell from the heart, lung, kidney, liver, bone marrow, pancreas, skin, bone, vein, artery, cornea, blood, small intestine, large intestine, brain, spinal cord, smooth muscle, skeletal muscle, ovary, testis, uterus, or umbilical cord.
96. The method of claim 1, wherein the biological matter comprises the following cell types: platelet, myelocyte, erythrocyte, lymphocyte, adipocyte, fibroblast, epithelial cell, endothelial cell, smooth muscle cell, skeletal muscle cell, endocrine cell, glial cell, neuron, secretory cell, barrier function cell, contractile cell, absorptive cell, mucosal cell, limbus cell (from cornea), stem cell, unfertilized or fertilized oocyte, or sperm.
97. The method of claim 1, further comprising taking the biological matter from the organism after inducing stasis.
98. The method of claim 97, further comprising transplanting or grafting the biological matter in a live recipient.
99. A method for inducing stasis in in vivo biological matter or an organism comprising administering to the organism an effective amount of a compound having a structure of:
wherein X is N, O, Po, S, Se, or Te;
wherein Y is N or O;
wherein R1 is H, C, lower alkyl, a lower alcohol, or CN;
wherein R2 is H, C, lower alkyl, or a lower alcohol, or CN;
wherein n is 0 or 1;
wherein m is 0 or 1;
wherein p is 1 or 2; and,
wherein k is 0, 1, 2, 3, or 4.
100. The method of claim 99, wherein the compound is a chalcogenide compound.
101. The method of claim 100, wherein the chalcogenide compound comprises sulfur.
102. (canceled)
103. (canceled)
104. (canceled)
105. The method of claim 11, wherein k is 0.
106. The method of claim 105, wherein the compound is selected from the group consisting of H2S, H2Se, H2Te, and H2Po.
107. The method of claim 99, wherein X is S.
108. The method of claim 107, wherein k is 0 or 1.
109. The method of claim 108, wherein k is 0.
110. The method of claim 99, wherein the compound is DMSO, DMS, carbon monoxide, methylmercaptan (CH3SH), mercaptoethanol, thiocyanate, hydrogen cyanide, MeSH, or CS2.
111. (canceled)
112. (canceled)
113. (canceled)
114. (canceled)
115. (canceled)
116. (canceled)
117. (canceled)
118. A method of 1) reducing oxygen demand in in vivo biological matter or organism 2) delaying the effects of a trauma on an organism, 3) for treating or preventing hemorrhagic shock in a patient; 4) reducing heart rate in an organism; 5) of inducing hibernation in an organism; 6) protecting an organism from radiation therapy or chemotherapy 7) treating a hyperproliferative disease in an organism; 8) inhibiting rejection of an organ transplant in an organism, 9) inducing cardioplegia in a patient undergoing bypass surgery 10) treating a patient with hyperthermia 11) preventing hematologic shock in a patient; 12) for promoting wound healing in an organism; 13) for preventing or treating neurodegeneration in an organism; or 14) for preserving an organism comprising contacting the biological matters, organism or patient with an effective amount of an oxygen antagonist.
119. (canceled)
120. (canceled)
121. (canceled)
122. (canceled)
123. (canceled)
124. (canceled)
125. (canceled)
126. The method of claim 118, wherein the method is for treating a subject with hypothermia the method further comprising subjecting the subject to an environmental temperature above that of the subject.
127. (canceled)
128. The method of claim 118, wherein the method is for treating hypothermia, further comprising (a) contacting the subject with an effective amount of an oxygen antagonist.
129. The method of claim 128, further comprising (b) subjecting the subject to an environmental temperature that is at least about 20\xb0 C. below that of the subject.
130. (canceled)
131. (canceled)
132. (canceled)
133. The method of claim 118 wherein the method is for preserving an organism.
134. The method of claim 133, wherein the organism is preserved for future consumption.
135. The method of claim 134, wherein the consumption is human consumption.
136. The method of claim 135, wherein the organism is a type of seafood.
137. The method of claim 133, wherein the organism is to be used for research purposes.
138. The method of claim 137, wherein the organism is a mouse.
139. The method of claim 11, wherein k is 0.

We claim:

1. A carrier for carrying a roll of metal plate having a hole defined therethrough, comprising:
a frame comprising a base adapted to extend into the hole of the roll; and
a support plate attached to the base of the frame, the support plate having an arcuate outer surface adapted to contact an inner surface of the metal plate.
2. The carrier as recited in claim 1, wherein a flexible cushion is attached to the arcuate outer surface of the support plate, for preventing the roll from being damaged.
3. The carrier as recited in claim 2, wherein the support plate defines a plurality of screw holes, the cushion defines a plurality of bores corresponding to the screw holes, and a plurality of screws extends into the bores and the screw holes for attaching the cushion to the support plate.
4. The carrier as recited in claim 1, wherein at least one rib is attached to the base of the frame, for supporting the support plate.
5. The carrier as recited in claim 1, wherein the frame comprises a beam extending in an upward direction from the base for abutting against the roll, and wherein a shield is attached to the beam for preventing the roll from being damaged by the beam.
6. The carrier as recited in claim 5, wherein the shield has an arcuate bottom edge corresponding to the arcuate outer surface of the support plate.
7. The carrier as recited in claim 5, wherein a top surface of the base of the frame is sloped upwardly from the beam to a free end of the base, for preventing the roll from sliding off the carrier.
8. The carrier as recited in claim 5, wherein the frame further comprises a boom extending from the beam and adapted for carrying the roll.
9. The carrier as recited in claim 8, wherein the boom defines a pair of openings at opposite ends thereof, and wherein the boom and the base extend from the beam in substantially the same direction.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A digital satellite transmission system to transmit a periodic unique word, comprising:
a transmitter to transmit the periodic unique word, the periodic unique word comprising a 64-symbol QPSK modulated waveform with baseband I and Q bits defined as
UWI=0x40F0B6EC088E3A21,
UWQ=0xEB498CA3B538F49D.
2. A digital storage media to store a unique word, comprising:
a memory to store the unique word, the unique word comprising baseband I and Q bits defined as
UWI=0x40F0B6EC088E3A21,
UWQ=0xEB498CA3B538F49D.
3. A frame format of a digital satellite transmission, comprising:
a plurality of frames, each frame having a fixed number of modulated symbols, regardless of a modulation type of the system, and each frame beginning with a unique word, wherein a spacing, in number of symbols, between any two consecutive unique words is identical, regardless of modulation type in the system, and a length of the pilot segments is adjustable.
4. A frame format of a digital satellite transmission, comprising:
a plurality of frames, each frame having a fixed number of modulated symbols, regardless of a modulation type of the system, and each frame beginning with a unique word,
wherein a spacing, in number of symbols, between any two consecutive unique words is identical, regardless of modulation type in the system, and the number of symbols per frame, excluding the unique word, an auxiliary control code and the pilot segments, perfectly accommodates a different number of codewords for each different modulation while maintaining a fixed frame length.
5. A frame format of a digital satellite transmission, comprising:
a plurality of frames, each frame having a fixed number of modulated symbols,
regardless of a modulation type of the system, and each frame beginning with a unique word,
wherein a spacing, in number of symbols, between any two consecutive unique words is identical, regardless of modulation type in the system, and network operation information andor other private information may be transmitted through a plurality of system information in a header of each frame.
6. A digital satellite receiver system to receive a signal with a periodic unique word designed to combat various impairments in satellite communication systems, comprising:
a receiver to receive a signal, wherein the receiver achieves synchronization to the signal based on the periodic unique word that undergoes a special pre-coding before a complex correlator and is QPSK modulated with I and Q defined as
UWI=0\xd740F0B6EC088E3A21
UWQ=0XEB498CA3B538F49D.
7. A digital satellite receiver system to process a received signal, comprising:
a receiver to receive the signal; and a processor to process the signal, wherein the signal comprises a frame format that contains a fixed number of modulated symbols per frame and a unique word at a beginning of each frame, and said receiver can decode all the codewords in a frame based on only a header embedded in the first codeword of the frame, regardless of number of codewords in the frame; the unique word is QPSK modulated with I and Q defined as
UWI=0\xd740F0B6EC088E3A21
UWQ=0XEB498CA3B538F49D.
8. The method of claim 7, wherein said receiver can decode a plurality of FEC codewords in a single frame, regardless of modulation employed.
9. The method of claim 7, wherein said receiver can process an inserted pilot segment of a given length if in a pilot operation mode.
10. The method of claim 9 wherein said receiver can decode network operation information andor other private information located immediately following a header field in each frame for any modulation.
11. A digital communications system, comprising: a transmitter to transmit a digital signal; and wherein the digital signal comprises a plurality of frames, each frame comprising at least one codeword, wherein said system supports at least two different modulations, each of the plurality of frames has the same number of symbols, and a first codeword in each frame comprises a header, the header comprising a plurality of system information to transmit network operator information.